Skip to main content
Viatris Inc logo

Viatris Inc — Investor Relations & Filings

Ticker · VTRS ISIN · US92556V1061 LEI · 254900ZZTSW7NL773X71 US Manufacturing
Filings indexed 489 across all filing types
Latest filing 2025-08-19 Director's Dealing
Country US United States of America
Listing US VTRS

About Viatris Inc

https://www.viatris.com/en

Viatris Inc. is a global healthcare company focused on empowering people to live healthier at every stage of life. The company operates by bridging the divide between generic and branded medicines, combining aspects of both to enhance patient access worldwide. Its portfolio comprises a wide range of high-quality medicines, including oral solid doses, injectables, complex dosage forms, and active pharmaceutical ingredients (APIs). These products cover numerous therapeutic areas, addressing both noncommunicable and infectious diseases. Viatris's offerings treat many of the World Health Organization's leading causes of death. The company continues to expand its capabilities, including recent acquisitions to strengthen its presence in the central nervous system (CNS) therapeutic area.

Recent filings

Filing Released Lang Actions
FORM 3
Director's Dealing
2025-08-19 English
FORM 4
Director's Dealing
2025-08-13 English
FORM 4
Director's Dealing
2025-08-13 English
FORM 3
Director's Dealing
2025-08-13 English
10-Q
Interim / Quarterly Report Q2 2025
2025-08-07 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-08-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.